Form 4: Guardant Health Director Meghan Joyce Reports Stock Transactions

Director Meghan Joyce reports the acquisition and disposition of Guardant Health (GH) common stock on June 4, 2024, including sales under a pre-arranged 10b5-1 plan.

Summary

• On June 4, 2024, Meghan V. Joyce, a director of Guardant Health, Inc. (GH), reported transactions involving the company's common stock.
• Joyce acquired 67 shares of common stock through the vesting of restricted stock units.
• She also disposed of 100 shares of common stock at a price of $27.87 per share.
• These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1.
• Following these transactions, Joyce beneficially owns 4,621 shares of Guardant Health common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock transactions by a director, with no explicit positive or negative implications. The 10b5-1 plan suggests a pre-determined strategy.

Positives

• The transactions were conducted under a pre-arranged 10b5-1 sales plan, indicating a pre-determined strategy and potentially mitigating concerns about insider trading.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future stock performance.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly increasing the stock's trading volume.

Key Dates